Carnosine And Anti-Ageing
Quick Read Carnosine is a small molecule your muscles naturally produce that declines with age. Research suggests it fights three
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
Vitamin B6 helps your body make serotonin and dopamine, chemicals that regulate mood. Researchers have tested whether B6 supplements help premenstrual syndrome, or PMS, by boosting these mood-regulating chemicals during the two weeks before a period when hormonal demands are high.
Multiple studies show B6 produces consistent improvements in emotional PMS symptoms like irritability, depression, and tiredness, rather than physical symptoms like bloating. The strongest evidence comes from a 2025 review of 31 trials with over 3,000 participants, which found B6 outperformed other nutritional interventions for psychological PMS symptoms. However, most individual studies had quality limitations, and study sizes were often small. Importantly, women with PMS don’t actually have lower B6 levels than those without PMS, suggesting the supplement works through a chemical boost rather than fixing a deficiency.
The safe effective dose appears to be 50 to 100mg daily. Higher doses, particularly long-term, carry a small risk of nerve damage. B6 is water-soluble and excess is excreted safely in urine, making it low-risk at recommended doses. Try it for at least two to three menstrual cycles before deciding whether it works for you.
Verdict: B6 is a safe, low-cost option with consistent but not definitive evidence, most helpful for mood-related PMS symptoms rather than physical ones.
Nearly half of all women of reproductive age experience premenstrual syndrome [1]. That’s not a niche health issue, that’s roughly one in two women dealing with mood shifts, irritability, fatigue, and a cluster of physical symptoms that arrive, predictably and unwelcomingly, every single month. So when vitamin B6 started appearing as a potential solution back in the 1970s and 80s, it spread fast, into GP surgeries, health food shops, and women’s magazines alike. Decades later, B6 is still one of the most commonly self-prescribed supplements for PMS. But does the science actually support the hype? The honest answer is: *more than sceptics suggest, less than enthusiasts claim*, and the nuance in between is genuinely worth understanding.
To understand why B6 even entered the PMS conversation, you need to understand what it does in the body. Vitamin B6, also called pyridoxine, is a co-factor in over 100 enzymatic reactions, several of which are directly relevant to mood regulation. Most notably, it plays a critical role in the synthesis of serotonin and dopamine, the neurotransmitters that regulate mood, motivation and emotional resilience. It’s also involved in tryptophan metabolism, the conversion of tryptophan (an amino acid) into serotonin.
The hypothesis that drove decades of research was elegant: if B6 is essential for serotonin production, and if the luteal phase of the menstrual cycle (the two weeks before a period) creates conditions of increased hormonal demand, perhaps some women become functionally deficient in B6 during that window, and supplementing could restore balance, reducing the emotional and psychological symptoms of PMS.
It’s a compelling mechanism. But as we’ll see, the relationship between B6 status, serotonin and PMS is considerably messier in practice than it is in theory.
Vitacuity analysed over 1.77 million research papers and selected the most relevant for this topic. Here’s what four decades of trials on B6 and PMS tell us, the promising findings, the inconsistencies, and the honest picture.
The most recent and methodologically rigorous piece of evidence in this area is a 2025 systematic review of 31 randomised controlled trials involving 3,254 participants, the largest body of evidence on nutritional interventions for PMS psychological symptoms assembled to date [1]. Researchers searched five electronic databases and used the Cochrane Risk of Bias tool to assess quality. Their finding? Of all the nutritional interventions reviewed, including vitamin D, magnesium, omega-3 fatty acids, whole-grain carbohydrates and soy isoflavones, only vitamin B6, calcium and zinc consistently showed significant positive effects on the psychological symptoms of PMS [1].
This is meaningful. Not because it’s a definitive green light, but because out of a crowded field of contenders, B6 kept rising to the top across multiple trials.
Evidence grade: Promising, consistent positive signals across multiple RCTs, but methodological quality is generally low and protocols vary significantly between studies.
One of the better-designed individual trials was a randomised double-blind crossover study published in 1989, involving 63 women aged 18–49 with moderate to severe premenstrual symptoms [14]. The dose used was 50mg of B6 per day, a modest, safe dose. After running participants through a full seven-month protocol (one baseline month, three months on the intervention, then crossover to placebo for three more months), 32 women completed the full study.
The findings: B6 produced a statistically significant improvement (p < 0.05) in emotional symptoms, specifically depression, irritability and tiredness [14]. No significant benefit was found for physical symptoms. The sample was small, and the dropout rate was notable (31 of 63 didn’t complete the full protocol), but this was a genuine double-blind crossover design, one of the better methodologies available for this type of research.
Evidence grade: Promising, good study design, but small sample and high dropout rate limit conclusions.
A 1988 retrospective survey of 630 women attending a PMS clinic between 1976 and 1983 reported on the therapeutic effect of pyridoxine at varying doses [5]. At 100–150mg per day, 40% or more of patients reported a ‘good’ response (no significant residual complaints). At 160–200mg per day, 60% of patients reported a good response. When partial responders were included, those who experienced useful benefit but still had some remaining symptoms, positive response rates rose to 65–88% depending on dose [5].
These numbers look impressive. But let’s be clear about what this was: a retrospective survey, not a controlled trial. There was no placebo group, no blinding, and the data was collected looking backwards. The placebo response in PMS trials is notoriously high, often 30–40% in controlled settings, which means we can’t draw firm causal conclusions from this data alone. What it does tell us is that a substantial proportion of women with PMS reported meaningful benefit, and that higher doses appeared to produce higher response rates, at least in this observational context.
Evidence grade: Traditional/Observational, large sample but no control group; placebo effect cannot be excluded.
One 1987 double-blind crossover study examined whether B6 affected platelet serotonin uptake in 19 women with PMS versus 19 symptom-free controls [7]. The researchers were testing the serotonin hypothesis directly. Their finding was interesting: B6 supplementation did increase Vmax (a measure of serotonin uptake capacity) significantly in both groups, but it did not improve PMS symptoms to a statistically significant degree, and there was no difference between B6 and placebo on symptom scores [7].
This is a genuinely puzzling result. B6 appears to be doing *something* biochemically, it’s changing serotonin uptake kinetics, but that change didn’t translate into measurable symptom relief in this small trial (n=38). One possibility: the relevant mechanism isn’t serotonin uptake but something earlier in the serotonin synthesis pathway, or perhaps the subgroup of women who respond to B6 are different from those who don’t.
Evidence grade: Early stage/conflicted, small sample, interesting mechanistic signal, but no clinical symptom benefit in this specific trial.
Two studies from 1986 specifically investigated whether women with PMS had lower B6 levels than women without PMS, testing the deficiency hypothesis at its root. One study measured multiple biochemical markers of B6 status in 19 women with PMS and 19 matched controls across a full menstrual cycle [4]. The other measured plasma pyridoxal-5′-phosphate (PLP, the active form of B6) in 210 women, comparing the 41 with moderate or severe PMS against the 95 with no or minimal symptoms [6].
Both studies found no significant difference in B6 status between women with and without PMS [4, 6]. In the larger study, mean plasma PLP values were virtually identical between the two groups (39.59 vs 40.56 nmol/L) [6]. The researchers concluded that B6 deficiency is unlikely to *cause* PMS.
This is an important finding, but it doesn’t necessarily mean supplementation won’t help. It suggests the mechanism isn’t simply “deficiency correction.” Rather, higher doses of B6 may be acting pharmacologically, shifting metabolic pathways in ways that go beyond simply topping up a depleted store. That’s a meaningful distinction for anyone trying to understand *why* B6 might work.
Evidence grade: Strong for the specific question (B6 deficiency doesn’t cause PMS), well-designed studies with clear biochemical measurements.
A 1987 double-blind controlled study of 55 women given 150mg of B6 daily found some benefit for specific symptom clusters, autonomic symptoms like dizziness and vomiting, and behavioural changes, but significant physical and affective symptoms remained, and the authors called for caution given concerns about neurological toxicity at even “low” doses [9]. A 2000 review echoed this concern, noting that high doses taken for prolonged periods can cause neurological symptoms [3].
This is worth understanding clearly. The risk of peripheral neuropathy from B6 is real, but it appears to be dose- and duration-dependent. The 1988 retrospective survey of 630 patients, which used doses of up to 200mg daily, reported no symptoms of peripheral neuropathy [5]. The UK Food Standards Agency sets the safe upper level at 10mg per day for long-term supplementation, though many researchers and clinicians have used 50–100mg in trials without reported harm. The key point: more is not better, and longer-term high-dose use (above 100mg daily) warrants care.
Evidence grade: Strong for the safety concern, this is well-established across multiple reviews.
Let’s be honest about the significant gaps in this research, because they matter.
The quality problem is real. The 2025 systematic review noted that only 1 of the 31 RCTs it analysed had a low risk of bias [1]. A 1990 literature review of 12 controlled trials on B6 and PMS concluded that evidence of positive effects was “weak,” and that “some well-designed trials with positive results would be needed to change this view” [13]. A 2000 commentary was more blunt: it noted that positive findings for B6 tended to come from lower-quality studies [12].
The placebo response is enormous. PMS symptom relief trials consistently show placebo response rates of 30–40% or higher. This makes it very hard to detect a genuine treatment effect unless trials are large, well-controlled, and run over multiple menstrual cycles. Most of the B6 trials to date have been too small and too short to confidently isolate the drug effect from placebo.
We don’t know who responds best. Some women report dramatic relief; others report nothing. We don’t have the research yet to identify which subgroups, by hormonal profile, dietary B6 intake, genetic variation in B6 metabolism, or symptom type, are most likely to benefit. The 1989 crossover trial found benefit specifically for *emotional* symptoms but not physical ones [14]; other trials show different symptom patterns. This heterogeneity suggests that PMS is not one condition, and B6 is not one intervention for all presentations.
The optimal dose remains unclear. Trials have used everything from 50mg to 200mg per day, with different durations, different formulations, and different timings within the cycle. We don’t know whether continuous daily supplementation is more effective than taking B6 only in the luteal phase. We don’t know whether the form matters (pyridoxine hydrochloride vs pyridoxal-5′-phosphate).
The mechanism remains partially unexplained. The serotonin hypothesis is plausible but unconfirmed. B6 doesn’t appear to work by correcting deficiency [4, 6], and its effect on serotonin uptake doesn’t reliably translate to symptom relief [7]. What it *is* doing to produce benefit in some women remains, frankly, unclear.
Here’s what a sensible, informed person would conclude from four decades of research on B6 and PMS.
B6 is not a proven cure, and anyone selling it as one is overstating the evidence. But “unproven” doesn’t mean “useless”, it means the research hasn’t yet been done at the scale and quality needed to deliver certainty. What we *do* have is consistent positive signals across multiple trials, a biologically plausible mechanism, and a supplement that, at sensible doses, is remarkably safe.
On dosage: The sweet spot in the research appears to be 50–100mg per day [14, 5]. Doses above 100mg, particularly long-term, carry a real (if historically rare in trial settings) risk of peripheral neuropathy [3, 9]. Stick to the lower end of what the evidence supports. The UK FSA’s 10mg daily guidance is very conservative for therapeutic use, but it’s worth knowing it exists.
On safety: B6 is water-soluble. At typical supplement doses of 10–50mg, excess is excreted in urine, the safety profile is excellent [3]. At therapeutic doses of 50–100mg used in PMS research, no serious adverse events were reported across multiple trials [14, 5]. This is a low-risk intervention.
On expectations: The evidence points most clearly to benefit for emotional and psychological symptoms of PMS, mood, irritability, depression, tiredness, rather than physical symptoms like bloating or breast tenderness [14, 1]. If your dominant PMS symptoms are emotional, B6 is a more rational first consideration than if your primary complaints are physical.
On timing: Try it for at least two to three full cycles before concluding it’s not working. PMS research generally shows that effects, when they appear, build over time.
On the broader picture: B6 doesn’t work in isolation. The same 2025 systematic review that highlighted B6 also flagged calcium and zinc as consistently beneficial for PMS psychological symptoms [1]. A good quality B-complex or targeted women’s health supplement that combines these nutrients is likely a more sensible approach than chasing any single ingredient.
The honest conclusion? If you experience moderate to severe PMS, particularly mood-related symptoms, B6 at a sensible dose is a safe, low-cost, biologically plausible intervention with consistent (if imperfect) trial evidence behind it. The risk of trying it is low; the potential benefit is real. A sensible, informed person would try it, track their symptoms honestly across several cycles, and see what happens.
That’s not a guarantee. But it’s a reasonable bet.
[1] Effect of nutritional interventions on the psychological symptoms of premenstrual syndrome in women of reproductive age: a systematic review of randomized controlled trials. (2025). *Nutrition Reviews*. DOI: 10.1093/nutrit/nuae043 | https://pubmed.ncbi.nlm.nih.gov/38684926/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11723155/
[2] Vitamin B6 and the premenstrual syndrome (PMS). (1985). https://pubmed.ncbi.nlm.nih.gov/3926696/
[3] The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. (2000). DOI: 10.1080/07315724.2000.10718907 | https://pubmed.ncbi.nlm.nih.gov/10682869/
[4] Vitamin B6 status of women suffering from premenstrual syndrome. (1986). https://pubmed.ncbi.nlm.nih.gov/3793524/
[5] Pyridoxine in the treatment of premenstrual syndrome: a retrospective survey in 630 patients. (1988). https://pubmed.ncbi.nlm.nih.gov/3256334/
[6] Plasma pyridoxal 5′-phosphate in women with the premenstrual syndrome. (1986). https://pubmed.ncbi.nlm.nih.gov/3957714/
[7] Platelet serotonin uptake and effects of vitamin B6-treatment in premenstrual tension. (1987). DOI: 10.1159/000118398 | https://pubmed.ncbi.nlm.nih.gov/3330183/
[8] Treatment of premenstrual symptoms in Wellington women. (1989). https://pubmed.ncbi.nlm.nih.gov/2919018/
[9] The effects of vitamin B6 supplementation on premenstrual symptoms. (1987). https://pubmed.ncbi.nlm.nih.gov/3299182/
[10] Vitamin B6 in the treatment of the premenstrual syndrome, review. (1991). https://pubmed.ncbi.nlm.nih.gov/2021578/
[11] Vitamin B-6 in premenstrual syndrome. (1990). https://pubmed.ncbi.nlm.nih.gov/2345264/
[12] Poor-quality studies suggest that vitamin B6 use is beneficial in premenstrual syndrome. (2000). DOI: 10.1136/ewjm.172.4.245-a | https://pubmed.ncbi.nlm.nih.gov/10778376/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1070858/
[13] Vitamin B6 in the treatment of the premenstrual syndrome, a review. (1990). https://pubmed.ncbi.nlm.nih.gov/2242373/
[14] Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. (1989). https://pubmed.ncbi.nlm.nih.gov/2558186/
[15] Vitamin B6 in premenstrual syndrome? (1992). https://pubmed.ncbi.nlm.nih.gov/1608344/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Carnosine is a small molecule your muscles naturally produce that declines with age. Research suggests it fights three
Quick Read CoQ10 is a molecule found in your cells’ power stations (mitochondria) that helps convert food into energy your
